Basic Information
| RNALocate ID: | RLID:01002427 |
| RNA Symbol: | hsa-miR-92b-3p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-miR-92b |
| RNA ID: | miRBase:MIMAT0003218 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S1.Top-ranking nucleolar miRNAs present in HeLa and MCF7 NCode arrays. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002428 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002429 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002430 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11003222 | Exosome | Peripheral blood | 31746410 |
| RLID:11003223 | Exosome | Plasma | 23663360 |
| RLID:11003224 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11003225 | Exosome | Cerebrospinal fluid | 25420022 |
| RLID:11003226 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11003227 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000160 | Exosome | Blood|B lymphoblastoid cells|Breast tissue|Endothelial cells|Kidney tissue|Lymphoma tissue|Mast cells|Tongue tissue | |
| RLID-D:11000512 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-92b-3p | Oral squamous cell carcinoma | MNDR-E-MI-71323 |
| MNDR | hsa-miR-92b-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-71324 |
| MNDR | hsa-miR-92b-3p | Uterine corpus endometrial carcinoma | MNDR-E-MI-71325 |
| MNDR | hsa-miR-92b-3p | Lymphoma | MNDR-E-MI-71326 |
| MNDR | hsa-miR-92b-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-71327 |
| MNDR | hsa-miR-92b-3p | Estrogen-receptor negative breast cancer | MNDR-E-MI-71328 |
| MNDR | hsa-miR-92b-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-71329 |
| MNDR | hsa-miR-92b-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-71330 |
| MNDR | hsa-miR-92b-3p | Her2-receptor positive breast cancer | MNDR-E-MI-71331 |
| MNDR | hsa-miR-92b-3p | Lupus nephritis | MNDR-E-MI-71332 |
| MNDR | hsa-miR-92b-3p | Colorectal carcinoma | MNDR-E-MI-71333 |
| MNDR | hsa-miR-92b-3p | Prostate cancer | MNDR-E-MI-71334 |
| MNDR | hsa-miR-92b-3p | Gastric cancer | MNDR-E-MI-71335 |
| MNDR | hsa-miR-92b-3p | Alzheimer disease | MNDR-E-MI-71336 |
| MNDR | hsa-miR-92b-3p | Polycystic ovary syndrome | MNDR-E-MI-71337 |
| MNDR | hsa-miR-92b-3p | Head and neck cancer | MNDR-E-MI-71338 |
| MNDR | hsa-miR-92b-3p | Graves disease | MNDR-E-MI-71339 |
| MNDR | hsa-miR-92b-3p | Leukemia | MNDR-E-MI-71340 |
| MNDR | hsa-miR-92b-3p | Cardiovascular disease | MNDR-E-MI-71341 |
| MNDR | hsa-miR-92b-3p | Brain cancer | MNDR-E-MI-71342 |
| MNDR | hsa-miR-92b-3p | Lung cancer | MNDR-E-MI-71343 |
| MNDR | hsa-miR-92b-3p | Down syndrome | MNDR-E-MI-71344 |
| MNDR | hsa-miR-92b-3p | Parkinson disease | MNDR-E-MI-71345 |
| MNDR | hsa-miR-92b-3p | Breast cancer | MNDR-E-MI-71346 |
| MNDR | hsa-miR-92b-3p | Neoplasms | MNDR-E-MI-71347 |
| MNDR | hsa-miR-92b-3p | Pancreatic cancer | MNDR-E-MI-71348 |
| MNDR | hsa-miR-92b-3p | Rectum adenocarcinoma | MNDR-E-MI-71349 |
| MNDR | hsa-miR-92b-3p | Nephroblastoma | MNDR-E-MI-71350 |
| MNDR | hsa-miR-92b-3p | Colon cancer | MNDR-E-MI-71351 |
| MNDR | hsa-miR-92b-3p | Colon adenocarcinoma | MNDR-E-MI-71352 |
| MNDR | hsa-miR-92b-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-71353 |
| MNDR | hsa-miR-92b-3p | Familial ovarian cancer | MNDR-E-MI-71354 |
| MNDR | hsa-miR-92b-3p | Carcinoma ductal breast | MNDR-E-MI-71355 |
| MNDR | hsa-miR-92b-3p | Glioblastoma | MNDR-E-MI-71356 |
| MNDR | hsa-miR-92b-3p | Astrocytoma | MNDR-E-MI-71357 |
| MNDR | hsa-miR-92b-3p | Glioma | MNDR-E-MI-71358 |
| MNDR | hsa-miR-92b-3p | Interstitial lung disease | MNDR-E-MI-71359 |
| MNDR | hsa-miR-92b-3p | Squamous cell neoplasm | MNDR-E-MI-71360 |
| MNDR | hsa-miR-92b-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-71361 |
| MNDR | hsa-miR-92b-3p | Epilepsy temporal lobe | MNDR-E-MI-71362 |
| MNDR | hsa-miR-92b-3p | Osteosarcoma | MNDR-E-MI-71363 |
| MNDR | hsa-miR-92b-3p | Liposarcoma | MNDR-E-MI-71364 |
| MNDR | hsa-miR-92b-3p | Breast carcinoma | MNDR-E-MI-71365 |
| MNDR | hsa-miR-92b-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-71366 |
| MNDR | hsa-miR-92b-3p | Infarction middle cerebral artery | MNDR-E-MI-71367 |
| MNDR | hsa-miR-92b-3p | Liver cancer | MNDR-E-MI-71368 |
| MNDR | hsa-miR-92b-3p | Cervical adenocarcinoma | MNDR-E-MI-71369 |
| MNDR | hsa-miR-92b-3p | Cervical squamous cell carcinoma | MNDR-E-MI-71370 |
| MNDR | hsa-miR-92b-3p | Carcinoma lung non-small-cell | MNDR-E-MI-71371 |
| MNDR | hsa-miR-92b-3p | Lung adenocarcinoma | MNDR-E-MI-71372 |
| MNDR | hsa-miR-92b-3p | Thyroid carcinoma | MNDR-E-MI-71373 |
| MNDR | hsa-miR-92b-3p | Ovarian carcinoma | MNDR-E-MI-71374 |
| MNDR | hsa-miR-92b-3p | Bladder urothelial carcinoma | MNDR-E-MI-71375 |
| MNDR | hsa-miR-92b-3p | Pancreatic adenocarcinoma | MNDR-E-MI-71376 |
| MNDR | hsa-miR-92b-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-71377 |
| MNDR | hsa-miR-92b-3p | Carcinoma renal cell | MNDR-E-MI-71378 |
| MNDR | hsa-miR-92b-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-71379 |
| MNDR | hsa-miR-92b-3p | Clear cell renal cell carcinoma | MNDR-E-MI-71380 |
| MNDR | hsa-miR-92b-3p | Cholangiocarcinoma | MNDR-E-MI-71381 |
| MNDR | hsa-miR-92b-3p | Esophageal cancer | MNDR-E-MI-71382 |
| MNDR | hsa-miR-92b-3p | Schizophrenia | MNDR-E-MI-71383 |
| MNDR | hsa-miR-92b-3p | Synovial sarcoma | MNDR-E-MI-71384 |
| MNDR | hsa-miR-92b-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-71385 |
| MNDR | hsa-miR-92b-3p | Heart failure | MNDR-E-MI-71386 |
| MNDR | hsa-miR-92b-3p | Breast invasive carcinoma | MNDR-E-MI-71387 |
| MNDR | hsa-miR-92b-3p | Hepatocellular carcinoma | MNDR-E-MI-71388 |
| MNDR | hsa-miR-92b-3p | Familiar ovarian carcinoma | MNDR-E-MI-71389 |
| MNDR | hsa-miR-92b-3p | Rheumatoid arthritis | MNDR-E-MI-71390 |
| MNDR | hsa-miR-92b-3p | Malignant pleural mesothelioma | MNDR-E-MI-71391 |
| MNDR | hsa-miR-92b-3p | Neuroblastoma | MNDR-E-MI-71392 |
| MNDR | hsa-miR-92b-3p | Neuromyelitis optica | MNDR-E-MI-71393 |
| MNDR | hsa-miR-92b-3p | Acute myelocytic leukemia | MNDR-E-MI-71394 |
| MNDR | hsa-miR-92b-3p | Colorectal cancer | MNDR-E-MI-71395 |
| MNDR | hsa-miR-92b-3p | Nasopharynx carcinoma | MNDR-E-MI-71396 |
| MNDR | hsa-miR-92b-3p | Nasopharyngeal cancer | MNDR-E-MI-71397 |
| MNDR | hsa-miR-92b-3p | Pseudorabies | MNDR-E-MI-71398 |
| MNDR | hsa-miR-92b-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-71399 |
| MNDR | hsa-miR-92b-3p | Subarachnoid hemorrhage traumatic | MNDR-E-MI-71400 |
| MNDR | hsa-miR-92b-3p | Stroke lacunar | MNDR-E-MI-71401 |
| MNDR | hsa-miR-92b-3p | Breast cancer her3+ negative | MNDR-E-MI-71402 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABHD13 | Homo sapiens | RR00025395 |
TOP